Patents by Inventor Navin Vaya

Navin Vaya has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10293048
    Abstract: A pharmaceutical composition and preparing processes thereof. The composition comprises bortezomib or pharmaceutically acceptable salt or solvate thereof, tromethamine and an organic carboxylic acid, and the pH of the composition is from about 3.0 to 6.0.
    Type: Grant
    Filed: March 1, 2013
    Date of Patent: May 21, 2019
    Assignee: DR. REDDY'S LABORATORIES LIMITED
    Inventors: Navin Vaya, Harshal Prabhakar Bhagwatwar, Rakeshwar Bandichhor, Nirmal Khati, Riyaz Ahmed Shaik, Rahul Bhise, Yakaswamy Asalla, Rajkumar Bhimrao Shinde
  • Patent number: 9655885
    Abstract: Aspects of the present invention relate to amorphous form of mirabegron, amorphous solid dispersion of mirabegron, process for its preparation, processes for preparation of ? form crystal and ? form crystal of mirabegron and pharmaceutical composition thereof.
    Type: Grant
    Filed: April 21, 2015
    Date of Patent: May 23, 2017
    Assignee: DR. REDDY'S LABORATORIES LTD.
    Inventors: Vishweshwar Peddy, Rajesham Boge, Yogesh S Gattani, Nagoji Shinde, Pradip Kumar Ghosh, Sritharan Seetharaman, Navin Vaya, Vaibhav Sihorkar, Rajashekhar Totad, Krishna Venkatesh, Ganesh Arun Katkar, Snehalatha Movva, Piyush Chudiwal
  • Publication number: 20150224087
    Abstract: Aspects of the present invention relate to amorphous form of mirabegron, amorphous solid dispersion of mirabegron, process for its preparation, processes for preparation of ? form crystal and ? form crystal of mirabegron and pharmaceutical composition thereof.
    Type: Application
    Filed: April 21, 2015
    Publication date: August 13, 2015
    Inventors: Vishweshwar PEDDY, Rajesham BOGE, Yogesh S. GATTANI, Nagoji SHINDE, Pradip Kumar GHOSH, Sritharan SEETHARAMAN, Navin VAYA, Vaibhav SIHORKAR, Rajashekhar TOTAD, Krishna VENKATESH, Ganesh Arun KATKAR, Snehalatha MOVVA, Piyush CHUDIWAL
  • Publication number: 20150051172
    Abstract: A pharmaceutical composition and preparing processes thereof. The composition comprises bortezomib or pharmaceutically acceptable salt or solvate thereof, tromethamine and an organic carboxylic acid, and the pH of the composition is from about 3.0 to 6.0.
    Type: Application
    Filed: March 1, 2013
    Publication date: February 19, 2015
    Inventors: Navin Vaya, Harshal Prabhakar Bhagwatwar, Rakeshwar Bandichhor, Nirmal Khati, Riyaz Ahmed Shaik, Rahul Bhise, Yakaswamy Asalla, Rajkumar Bhimrao Shinde
  • Publication number: 20140142153
    Abstract: Aspects of the present appliction relate to pharmaceutical formulations comprising bendamustine or its pharmaceutically acceptable salts, isomers, racemates, enantiomers, hydrates, solvates, metabolites, polymorphs, and mixtures therof, suitable for phamaceutical use. Aspects further provide methods of producing stable bendamustine compositions.
    Type: Application
    Filed: January 25, 2012
    Publication date: May 22, 2014
    Applicants: DR. REDDY'S LABORATORIES, INC., DR. REDDY'S LABORATORIES LTD.
    Inventors: Chandrasekhar Kocherlakota, Tarun Singh, Nagaraju Banda, Nirmal Khati, Sachin Sharma, Prasad Vure, Aparna Mulupuru, Navin Vaya, Amit Anil Charkha
  • Publication number: 20140051733
    Abstract: The present application discloses stable pharmaceutical compositions for the oral administration of febuxostat with pharmaceutical excipients which provide improved dissolution rate and polymorphic stability both while manufacturing and during storage and process for preparing the stable compositions, packaging and their use in the treatment of gout of hyperuricemia.
    Type: Application
    Filed: August 12, 2013
    Publication date: February 20, 2014
    Applicant: Dr. Reddy's Laboratories Ltd.
    Inventors: Sunil Beeram Reddy, Amarnath Suseendharnath, Manikandan Ramalingam, Venkatesh Madhavacharya, Navin Vaya, Harshal Prabhakar Bhagwatwar, Venkateswarlu Vobalaboina
  • Patent number: 8268352
    Abstract: A novel modified release dosage form comprising of a high solubility active ingredient, which utilizes dual retard technique to effectively reduce the quantity of release controlling agents. Present invention can optionally comprise additionally another active ingredient as an immediate release form or modified release form. Present invention also relates to a process for preparing the said formulation.
    Type: Grant
    Filed: May 19, 2005
    Date of Patent: September 18, 2012
    Assignee: Torrent Pharmaceuticals Limited
    Inventors: Navin Vaya, Rajesh Singh Karan, Sunil Sadanand Nadkarni, Vinod Kumar Gupta
  • Patent number: 8263125
    Abstract: A dosage form comprising of a high dose, high solubility active ingredient as modified release and a low dose active ingredient as immediate release where the weight ratio of immediate release active ingredient and modified release active ingredient is from 1:10 to 1:15000 and the weight of modified release active ingredient per unit is from 500 mg to 1500 mg; a process for preparing the dosage form.
    Type: Grant
    Filed: May 19, 2005
    Date of Patent: September 11, 2012
    Assignee: Torrent Pharmaceuticals Limited
    Inventors: Navin Vaya, Rajesh Singh Karan, Sunil Sadanand Nadkarni, Vinod Kumar Gupta
  • Patent number: 8216609
    Abstract: A novel modified release dosage form comprising of a high solubility active ingredient, which utilizes dual retard technique to effectively reduce the quantity of release controlling agents; a process for preparing the dosage form.
    Type: Grant
    Filed: July 29, 2003
    Date of Patent: July 10, 2012
    Assignee: Torrent Pharmaceuticals Limited
    Inventors: Navin Vaya, Rajesh Singh Karan, Sunil Sadanand Nadkarni, Vinod Kumar Gupta
  • Publication number: 20120121700
    Abstract: Pharmaceutical formulations prepared by granulating valganciclovir or a salt thereof, using a nonaqueous solvent or hydro-alcohol.
    Type: Application
    Filed: November 14, 2011
    Publication date: May 17, 2012
    Inventors: Vaibhav Dubey, Mamta Mishra, Ramakant Gundu, Navin Vaya, Harshal Prabhakar Bhagwatwar
  • Publication number: 20120058194
    Abstract: Stabilized substituted benzimidazole modified release pharmaceutical formulations with at least two drug-containing fractions, wherein the release from a first fraction precedes the release from a second fraction, pharmaceutical excipients, processes for preparing the stable formulations, packaging therefor, and their use in treatment of erosive esophagitis and heartburn associated with non-erosive gastroesophageal reflux disease.
    Type: Application
    Filed: August 25, 2011
    Publication date: March 8, 2012
    Inventors: Navin Vaya, Mamta Mishra, Atul Shivaji Shinde, Harshal Prabhakar Bhagwatwar, Debashis Dash, Deepti Jain, Rahul Sudhakar Gawande, Vishal Lad, Sushant Dube, Venkateswarlu Vobalaboina, Srinivas Irukulla, Manikandan Ramalingam
  • Patent number: 7985422
    Abstract: A dosage form comprising of a high dose, high solubility active ingredient as modified release and a low dose active ingredient as immediate release where the weight ratio of immediate release active ingredient and modified release active ingredient is from 1:10 to 1:15000 and the weight of modified release active ingredient per unit is from 500 mg to 1500 mg; a process for preparing the dosage form.
    Type: Grant
    Filed: July 29, 2003
    Date of Patent: July 26, 2011
    Assignee: Torrent Pharmaceuticals Limited
    Inventors: Navin Vaya, Rajesh Singh Karan, Sunil Sadanand Nadkarni, Vinod Kumar Gupta
  • Patent number: 7976871
    Abstract: A novel modified release dosage form comprising of a high solubility active ingredient, which utilizes dual retard technique to effectively reduce the quantity of release controlling agents. Present invention can optionally comprise additionally another active ingredient as an immediate release form or modified release form. Present invention also relates to a process for preparing the said formulation.
    Type: Grant
    Filed: May 19, 2005
    Date of Patent: July 12, 2011
    Assignee: Torrent Pharmaceuticals Limited
    Inventors: Navin Vaya, Rajesh Singh Karan, Sunil Sadanand Nadkarni, Vinod Kumar Gupta
  • Patent number: 7939102
    Abstract: Rapidly disintegrating multiparticulate controlled release formulations of lamotrigine having an improved pharmacokinetic profile and improved patient compliance, and process of preparing the formulations. It provides better control of blood plasma levels than conventional tablet formulations that is administered once or more times a day.
    Type: Grant
    Filed: June 2, 2003
    Date of Patent: May 10, 2011
    Assignees: Torrent Pharmaceuticals Ltd., Torrent Pharmaceuticals Torrent Research Center
    Inventors: Sunil Sadanand Nadkarni, Navin Vaya
  • Publication number: 20060153916
    Abstract: A dosage form comprising of a high dose, high solubility active ingredient as modified release and a low dose active ingredient as immediate release where the weight ratio of immediate release active ingredient and modified release active ingredient is from 1:10 to 1:15000 and the weight of modified release active ingredient per unit is from 500 mg to 1500 mg; a process for preparing the dosage form.
    Type: Application
    Filed: August 1, 2003
    Publication date: July 13, 2006
    Inventors: Navin Vaya, Rajesh Karan, Sunil Nadkarni, Vinod Qupta
  • Publication number: 20060024365
    Abstract: A dosage form comprising of a high dose, high solubility active ingredient as modified release and a low dose active ingredient as immediate release where the weight ratio of immediate release active ingredient and modified release active ingredient is from 1:10 to 1:15000 and the weight of modified release active ingredient per unit is from 500 mg to 1500 mg; a process for preparing the dosage form.
    Type: Application
    Filed: May 19, 2005
    Publication date: February 2, 2006
    Inventors: Navin Vaya, Rajesh Karan, Sunil Sadanand, Vinod Gupta
  • Publication number: 20060018934
    Abstract: A novel modified release dosage form comprising of a high solubility active ingredient, which utilizes dual retard technique to effectively reduce the quantity of release controlling agents. Present invention can optionally comprise additionally another active ingredient as an immediate release form or modified release form. Present invention also relates to a process for preparing the said formulation.
    Type: Application
    Filed: May 19, 2005
    Publication date: January 26, 2006
    Inventors: Navin Vaya, Rajesh Karan, Sunil Nadkarni, Vinod Gupta
  • Publication number: 20060018933
    Abstract: A novel modified release dosage form comprising of a high solubility active ingredient, which utilizes dual retard technique to effectively reduce the quantity of release controlling agents. Present invention can optionally comprise additionally another active ingredient as an immediate release form or modified release form. Present invention also relates to a process for preparing the said formulation.
    Type: Application
    Filed: May 19, 2005
    Publication date: January 26, 2006
    Inventors: Navin Vaya, Rajesh Karan, Sunil Nadkarni, Vinod Gupta
  • Publication number: 20040096501
    Abstract: A novel modified release dosage form comprising of a high solubility active ingredient, which utilizes dual retard technique to effectively reduce the quantity of release controlling agents; a process for preparing the dosage form.
    Type: Application
    Filed: July 29, 2003
    Publication date: May 20, 2004
    Inventors: Navin Vaya, Rajesh Singh Karan, Sunil Sadanand Madkarni, Vinod Kumar Gupta
  • Publication number: 20040096499
    Abstract: A dosage form comprising of a high dose, high solubility active ingredient as modified release and a low dose active ingredient as immediate release where the weight ratio of immediate release active ingredient and modified release active ingredient is from 1:10 to 1:15000 and the weight of modified release active ingredient per unit is from 500 mg to 1500 mg; a process for preparing the dosage form.
    Type: Application
    Filed: July 29, 2003
    Publication date: May 20, 2004
    Inventors: Navin Vaya, Rajesh Singh Karen, Sunil Sadanand Nadkarni, Vinod Kumar Gupta